The Socioeconomic Burden of Coronary Heart Disease in Korea
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Objectives: We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data. Methods: A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective. Results: Estimated national spending on CHD in 2005 was $2.52 billion. The majority of the spending was attributable to medical costs (53.3%), followed by productivity loss due to morbidity and premature death (33.6%), transportation (8.1%), and informal caregiver costs (4.9%). While medical cost was the predominant cost attribute in treating angina (74.3% of the total cost), premature death was the largest cost attribute for patients with MI (66.9%). Annual per-capita cost of treating MI, excluding premature death cost, was $3183,which is about 2 times higher than the cost for angina ($1556). Conclusions: The total insurance-covered medical cost ($1.13 billion) of CHD accounted for approximately 6.02% of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea.
Abstract
Objectives: We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data. Methods: A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective. Results: Estimated national spending on CHD in 2005 was $2.52 billion. The majority of the spending was attributable to medical costs (53.3%), followed by productivity loss due to morbidity and premature death (33.6%), transportation (8.1%), and informal caregiver costs (4.9%). While medical cost was the predominant cost attribute in treating angina (74.3% of the total cost), premature death was the largest cost attribute for patients with MI (66.9%). Annual per-capita cost of treating MI, excluding premature death cost, was $3183,which is about 2 times higher than the cost for angina ($1556). Conclusions: The total insurance-covered medical cost ($1.13 billion) of CHD accounted for approximately 6.02% of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea.
참고문헌 (35)
- Reddy KS, "Emerging epidemic of cardiovascular disease in developing countries", Circulation, 97(6), pp.596~601 (1998)
- Lopez AD, "Assessing the burden of mortality from cardiovascular diseases", World Health Stat Q, 46(2), pp.91~96 (1993)
- Sekikawa A, "Coronary heart disease mortality trends in men in the post World War II birth cohorts aged 35-44 in Japan, South Korea and Taiwan compared with the United States", Int J Epidemiol, 28(6), pp.1044~1049 (1999)
- Kesteloot H, "Changes in all-cause and cardiovascular mortality rates in Eastern Europe: a missed opportunity", Acta Cardiol, 56(5), pp.273~275 (2001)
- Khang YH, "Impact of economic crisis on cause-specific mortality in South Korea", Int J Epidemiol, 34(6), pp.1291~1301 (2005)
- Chun BY, "The incidence rate of coronary heart disease in city area", Korean J Prev Med, 31(3), pp.395~403 (1998)
- Health Insurance Review Agency, "2005 National health insurance statistical yearbook", Health Insurance Review Agency, National Health Insurance Corporation, 408~412 (2006)
- Cheng Y, "Secular trends in coronary heart disease mortality, hospitalization rates, and major cardiovascular risk factors in Taiwan, 1971-2001", Int J Cardiol, 100(1), pp.47~52 (2005)
- Zethraeus N, "Costs of coronary heart disease and stroke: the case of Sweden", J Intern Med, 246(2), pp.151~159 (1999)
- Liu JL, "The economic burden of coronary heart disease in the UK", Heart, 88(6), pp.597~603 (2002)
- Rice DP, "The economic costs of the health effects of smoking, 1984", Milbank Q, 64(4), pp.489~547 (1986)
- Munk EM, "Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest", epigastric pain and normal upper endoscopy: a 10-year Danish cohort study, 2007, pp.25(10), 1203~1210
- Sorensen HT, "Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis", Circulation, 124(13), pp.1435~1441 (2011)
- "Korean National Health and Nutrition Examination Survey II, III"[URL]
- "2005 Survey report on wage structure"[URL]
- "2005 Cause of death statistics"[URL]
- Drummmond MF, "Methods for the economic evaluation of health care programmes. 3rd ed", pp.78~88 (2005), Oxford University Press
- 강혜영, "우리나라 노인여성의 골다공증성 척추골절로 인한 경제적 부담 추계", 예방의학회지, 41(5), pp.287~294 (2008), 대한예방의학회
- Socioeconomic costs of alcohol and policy issues, "No IC", Korea Institute for Health and Social Affairs, 80~82 (1997)
- "Life time table 2007" (2008)[URL]
- Health Insurance Review and Assessment Service, "Guidelines for economic evaluation of pharmaceuticals in Korea and data handling", Health Insurance Review and Assessment Service, 33~34 (2006)
- 정영호, "5대 사망원인 질병의 사회, 경제적 비용추계", 재정논집, 18(2), pp.77~104 (2004), 한국재정학회
- 임승지, "건강보험 청구자료를 이용한 우리나라 뇌졸중 환자의 사회경제적 비용 추계", 예방의학회지, 42(4), pp.251~260 (2009), 대한예방의학회
- 김진희, "2005년 암의 경제적 비용부담 추계", 예방의학회지, 42(3), pp.190~198 (2009), 대한예방의학회
- Cheng A, "Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy", Clin Cardiol, 25(5), pp.205~212 (2002)
- Leal J, "Economic burden of cardiovascular diseases in the enlarged European Union", Eur Heart J, 27(13), pp.1610~1619 (2006)
- Luengo-Fernandez R, "Cost of cardiovascular diseases in the United Kingdom", Heart, 92(10), pp.1384~1389 (2006)
- Ford ES, "Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates", J Am Coll Cardiol, 50(22), pp.2128~2132 (2007)
- Russell MW, "Direct medical costs of coronary artery disease in the United States", Am J Cardiol, 81(9), pp.1110~1115 (1998)
- Ramsey SD, "How should we value lives lost to cancer?", J Natl Cancer Inst, 100(24), pp.1742~1743 (2008)
- Swahn E, "The care of patients with ischaemic heart disease from a gender perspective", Eur Heart J, 19(12), pp.1758~1765 (1998)
- Hemingway H, "Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries", Circulation, 117(12), pp.1526~1536 (2008)
- Lerner DJ, "Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population", Am Heart J, 111(2), pp.383~390 (1986)
- Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance database, "Park BJ", Seoul National University, ~ (2003)
- European cardiovascualr disease statitstics, "Allender S", University of Oxford, 107~ (2008)